翔宇医疗：目前主要聚焦非侵入式脑机接口技术，截至2025年末尚未实现规模化销售

Core Viewpoint - The stock of Xiangyu Medical has experienced significant volatility, with a cumulative price deviation of 30% over three consecutive trading days, attributed to heightened market interest in brain engineering and brain-computer interface concepts [1] Company Focus - The company is primarily focused on non-invasive brain-computer interface technology, which encompasses a comprehensive range of rehabilitation scenarios including occupational therapy, motor therapy, cognitive speech, and swallowing [1] - This approach differs from the current international trend towards invasive brain-computer interface technologies [1] Market Position and Development - The company has made investments in brain-computer interface technology, establishing a certain level of layout in technology, products, and market channels [1] - However, the bidding and sales processes exhibit a lag, and as of the end of 2025, related products are not expected to achieve large-scale sales, resulting in a relatively small revenue contribution [1]